These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35377464)

  • 1. Lack of clinically relevant differences in safety and pharmacokinetics after second-dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis.
    Cascino GD; Tarquinio D; Wheless JW; Hogan RE; Sperling MR; Desai J; Vazquez B; Samara E; Misra SN; Carrazana E; Rabinowicz AL;
    Epilepsia; 2022 Jul; 63(7):1714-1723. PubMed ID: 35377464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy.
    Wheless JW; Miller I; Hogan RE; Dlugos D; Biton V; Cascino GD; Sperling MR; Liow K; Vazquez B; Segal EB; Tarquinio D; Mauney W; Desai J; Rabinowicz AL; Carrazana E;
    Epilepsia; 2021 Oct; 62(10):2485-2495. PubMed ID: 34418086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of second doses of Valtoco® (diazepam nasal spray) across 24 hours after the initial dose for out-of-hospital seizure clusters: Results from a phase 3, open-label, repeat-dose safety study.
    Sperling MR; Wheless JW; Hogan RE; Dlugos D; Cascino GD; Liow K; Rabinowicz AL; Carrazana E;
    Epilepsia; 2022 Apr; 63(4):836-843. PubMed ID: 35112342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Diazepam Nasal Spray in Children and Adolescents With Epilepsy: Results From a Long-Term Phase 3 Safety Study.
    Tarquinio D; Dlugos D; Wheless JW; Desai J; Carrazana E; Rabinowicz AL
    Pediatr Neurol; 2022 Jul; 132():50-55. PubMed ID: 35636283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of prolonged seizure with diazepam nasal spray: An exploratory post hoc cohort analysis.
    Jarrar R; Stern JM; Becker DA; Davis C; Rabinowicz AL; Carrazana E
    Epilepsy Behav; 2024 Oct; 159():109987. PubMed ID: 39181105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and safety of VALTOCO (NRL-1; diazepam nasal spray) in patients with epilepsy during seizure (ictal/peri-ictal) and nonseizure (interictal) conditions: A phase 1, open-label study.
    Hogan RE; Tarquinio D; Sperling MR; Klein P; Miller I; Segal EB; Rabinowicz AL; Carrazana E
    Epilepsia; 2020 May; 61(5):935-943. PubMed ID: 32338380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistent safety and tolerability of Valtoco
    Miller I; Wheless JW; Hogan RE; Dlugos D; Biton V; Cascino GD; Sperling MR; Liow K; Vazquez B; Segal EB; Tarquinio D; Mauney W; Desai J; Rabinowicz AL; Carrazana E;
    Epilepsia Open; 2021 Sep; 6(3):504-512. PubMed ID: 34033266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long-term, open-label safety study.
    Segal EB; Tarquinio D; Miller I; Wheless JW; Dlugos D; Biton V; Cascino GD; Desai J; Hogan RE; Liow K; Sperling MR; Vazquez B; Cook DF; Rabinowicz AL; Carrazana E;
    Epilepsia; 2021 Jun; 62(6):1442-1450. PubMed ID: 33942315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant improvements in SEIzure interVAL (time between seizure clusters) across time in patients treated with diazepam nasal spray as intermittent rescue therapy for seizure clusters.
    Misra SN; Sperling MR; Rao VR; Peters JM; Davis C; Carrazana E; Rabinowicz AL
    Epilepsia; 2022 Oct; 63(10):2684-2693. PubMed ID: 35975599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant cannabidiol does not impact safety and effectiveness of diazepam nasal spray for seizure clusters: Post hoc analysis of a phase 3 safety study.
    Peters JM; Puri V; Segal E; Misra SN; Rabinowicz AL; Carrazana E
    Epilepsy Behav; 2023 Jul; 144():109248. PubMed ID: 37210793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Rescue Treatment with Diazepam Nasal Spray Leads to Faster Seizure Cluster Termination in Epilepsy: An Exploratory Post Hoc Cohort Analysis.
    Misra SN; Jarrar R; Stern JM; Becker DA; Carrazana E; Rabinowicz AL
    Neurol Ther; 2024 Feb; 13(1):221-231. PubMed ID: 38175488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of observed tolerance to diazepam nasal spray (Valtoco®) after long-term rescue therapy in patients with epilepsy: Interim results from a phase 3, open-label, repeat-dose safety study.
    Cascino GD; Tarquinio D; Wheless JW; Hogan RE; Sperling MR; Liow K; Desai J; Davis C; Rabinowicz AL; Carrazana E;
    Epilepsy Behav; 2021 Jul; 120():107983. PubMed ID: 33957437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming the challenges of developing an intranasal diazepam rescue therapy for the treatment of seizure clusters.
    Cloyd J; Haut S; Carrazana E; Rabinowicz AL
    Epilepsia; 2021 Apr; 62(4):846-856. PubMed ID: 33617690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effectiveness of diazepam nasal spray in male and female patients: Post hoc analysis of data from a phase 3 safety study.
    Wheless JW; Hogan RE; Davis CS; Carrazana E; Rabinowicz AL
    Epilepsia Open; 2024 Apr; 9(2):793-799. PubMed ID: 38340025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality-of-life results in adults with epilepsy using diazepam nasal spray for seizure clusters from a long-term, open-label safety study.
    Cramer JA; Faught E; Davis C; Misra SN; Carrazana E; Rabinowicz AL
    Epilepsy Behav; 2022 Sep; 134():108811. PubMed ID: 35816831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of seizure-cluster circadian periodicity from a long-term, open-label safety study of diazepam nasal spray.
    Fountain NB; Quigg M; Murchison CF; Carrazana E; Rabinowicz AL
    Epilepsia; 2024 Apr; 65(4):920-928. PubMed ID: 38391291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of observed impact of history or concomitant treatment of seasonal allergies or rhinitis on repeated doses of diazepam nasal spray administered per seizure episode in a day, safety, and tolerability: Interim results from a phase 3, open-label, 12-month repeat-dose safety study.
    Vazquez B; Wheless J; Desai J; Rabinowicz AL; Carrazana E
    Epilepsy Behav; 2021 May; 118():107898. PubMed ID: 33752044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters: Results from an exit survey of a phase 3, open-label, repeat-dose safety study.
    Penovich P; Wheless JW; Hogan RE; Guerra C; Cook DF; Carrazana E; Rabinowicz AL
    Epilepsy Behav; 2021 Aug; 121(Pt A):108013. PubMed ID: 34022621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepines for the Treatment of Seizure Clusters.
    Penovich PE; Rao VR; Long L; Carrazana E; Rabinowicz AL
    CNS Drugs; 2024 Feb; 38(2):125-140. PubMed ID: 38358613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of a diazepam nasal spray for the treatment of acute seizure clusters and prolonged seizures.
    Higdon LM; Sperling MR
    Expert Rev Neurother; 2021 Nov; 21(11):1207-1212. PubMed ID: 34374629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.